12 Results for "

saphenous vein

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "saphenous vein" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-170230
Synonyms: ECGS,Bovine
Bovine Endothelial cell growth supplement, suitable for cell culture (ECGS, Bovine) is a culture medium supplement, endothelial cell growth supplement (ECGS), which promotes the proliferation of human saphenous vein endothelial cells (HSVEC) and human umbilical vein endothelial cells (HUVEC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1856
CAS No.: 33017-11-7
Proinsulin C-peptide (human) is a peptide consisting of 31 amino acids that links the A and B chains of proinsulin to ensure its correct folding. Proinsulin C-peptide (human) inhibits the high glucose-induced increase in PDGF-β receptor protein expression and the phosphorylation of p42/p44 MAP kinase. Proinsulin C-peptide (human) increases the deformability of erythrocytes derived from type 1 diabetes, inhibits insulin-induced neointimal thickening, and suppresses the proliferation of rat aortic smooth muscle cells cultured under high-glucose conditions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10419A
CAS No.: 81496-19-7
Research Areas:  

Cardiovascular Disease

AH23848 hemicalcium salt is an orally active, selective competitive blocker of the thromboxane A2 receptor, with an IC50 value of 50 nM. AH23848 hemicalcium salt shows no activity against other prostaglandin, serotonin (5-HT) or adenosine diphosphate (ADP) receptors. AH23848 hemicalcium salt can be used in the research of occlusive vascular diseases .
loading...
    loading...
Cat. No.: HY-B1107
CAS No.: 3200-06-4
Synonyms: Nafronyl oxalate salt
Target:  

5-HT Receptor

Research Areas:  

Cardiovascular Disease

Naftidrofuryl oxalate (Nafronyl oxalate salt) is an orally active 5-HT2 receptor antagonist. Naftidrofuryl oxalate selectively blocks vascular and platelet 5-HT2 receptors, inhibiting Serotonin (HY-B1473A)-induced vasoconstriction, platelet aggregation, and vascular smooth muscle cell proliferation. Naftidrofuryl oxalate can be used for the research of intermittent claudication, peripheral occlusive arterial disease, and critical limb ischaemia .
loading...
    loading...
Cat. No.: HY-P3433
CAS No.: 120972-53-4
Target:  

Endothelin Receptor

Research Areas:  

Cardiovascular Disease

Sarafotoxin S6b is a vasoconstrictor peptide, and a non-selective endothelin receptor agonist. Sarafotoxin S6b can induce contraction in isolated human coronary arteries , the Ki values of Coronary artery, Saphenous vein and Coronary artery are 0.27, 0.55 and 19.5 nM, respectively .
loading...
    loading...
Cat. No.: HY-10419
CAS No.: 81443-73-4
Research Areas:  

Cardiovascular Disease

AH23848 (compound 6) is a competitive blocker of the thromboxane A2 receptor and an orally effective agent, with an IC50 value of 50 nM against human targets and a long duration of action.
loading...
    loading...
Cat. No.: HY-103459
CAS No.: 162256-50-0
Synonyms: PD156707
Target:  

Endothelin Receptor

Research Areas:  

Cardiovascular Disease

CI-1020 (PD156707) is an orally active and selective antagonist targeting endothelin (ETA) with an IC50 value of 0.3 nM. CI-1020 blocks intimal hyperplasia in human saphenous veins completely in organ culture. CI 1020 inhibits hypoxic pulmonary hypertension and blocks ET-1-induced pressor responses following oral administration .
loading...
    loading...
Cat. No.: HY-135079
CAS No.: 54765-26-3
Lerimazoline is a selective 5-HT1D receptor agonist with Ki values of 72 and 3480 nM for h5-HT1D and h5-HT1B. Lerimazoline inhibits Forskolin (HY-15371)-stimulated cAMP production and induces contractions in rabbit saphenous vein preparations. Lerimazoline can be used for the research of migraine .
loading...
    loading...
Cat. No.: HY-19138
CAS No.: 135809-60-8
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

SR 47063 is an ATP-sensitive potassium channel (KATP) agonist. SR 47063 selectively activates KATP channels in vascular smooth muscle cells (IC50: 8.1 nM in human saphenous vein, 3.86 nM in rat aorta). SR 47063 promotes potassium efflux and cellular hyperpolarization to induce vasorelaxation. SR 4706 is promising for research of hypertension and related cardiovascular disorders .
loading...
    loading...
Cat. No.: HY-183399
CAS No.: 95669-35-5
Wy 27127 is a potent and selective α2-adrenergic receptor antagonist. Wy 27127 competitively blocks α2-adrenergic receptors, interrupts the negative feedback loop of sympathetic nerve endings, enhances stimulus-evoked norepinephrine release, and blocks agonist-induced inhibition of vas deferens contraction. Wy 27127 shows weak antagonistic effects on α1 receptors, and exhibits no significant antagonistic activity against 5-hydroxytryptamine, muscarinic, presynaptic dopamine, histamine or β1-adrenergic receptors in vitro. Wy 27127 blocks saphenous vein contraction mediated by postsynaptic α2-adrenergic receptor agonists. Wy 27127 is applicable to studies related to sympathetic neurotransmission and vascular adrenergic responses .
loading...
    loading...
Cat. No.: HY-111290
CAS No.: 85278-24-6
Target:  

VAP-1

Research Areas:  

Cardiovascular Disease

(E)-MDL72274 hydrochloride is a semicarbazide-sensitive amine oxidase (SSAO) inhibitor with an IC50 value of 0.74-1.42 μM. (E)-MDL72274 hydrochloride inhibits allylamine-induced excessive contraction of isolated coronary artery bypass graft vessels. (E)-MDL72274 hydrochloride can be used in studies related to vasospasm .
loading...
    loading...
Cat. No.: HY-18101
CAS No.: 150208-28-9
Research Areas:  

Neurological Disease

BD-1063 is a selective σ-1 receptor antagonist with inhibitory activity against TRPC5 and TRPM3. BD-1063 exerts anti-hyperalgesic and anti-allodynic effects by inhibiting sustained calcium influx mediated by TRPC5 and TRPM3, and reverses the effects of Carrageenan (HY-125474). BD-1063 also significantly reduces excessive ethanol self-administration behavior. BD-1063 is widely used in studies on the mechanisms underlying neuropathic pain, inflammatory hyperalgesia, and alcohol abuse and dependence .
loading...
    loading...
  • 1